XT
NKGN

XTX Topco’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

XTX Topco’s Portfolio NKGN Stock Details NKGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-33,625
Closed -$22K – 3283
2024
Q4 		$22K Buy
+33,625
New +$13.7K ﹤0.01% 2027

Other funds holding NKGN

DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
UOC
University of Chicago Chicago, Illinois $323M AUM 14.1% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

XTX Topco's NKGN Position: Q1 2025 in Review

XTX Topco sold out of NKGen Biotech, Inc. Common Stock (NKGN) in Q1 2025, closing a stake of 33,625 shares — an estimated $22K sold.

XTX Topco first reported a position in NKGN in Q4 2024 and held it in 1 quarter. The position peaked at $22K in Q4 2024. 3 funds tracked by Wall St. Rank hold NKGN as of Q1 2025.

  • XTX Topco reported no remaining NKGen Biotech, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • XTX Topco sold 33,625 NKGen Biotech, Inc. Common Stock shares in Q1 2025, an estimated $22K.
  • XTX Topco first reported a position in NKGen Biotech, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
  • XTX Topco's NKGen Biotech, Inc. Common Stock position peaked at $22K in Q4 2024.
  • 3 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Common Stock as of Q1 2025.

Based on XTX Topco's 13F filing for Q1 2025, filed 8 May 2025.